Table 3.

Comparison of the prognosis for the coagulative necrosis and liquefactive necrosis groups.

	Coagulative necrosis group (months) (median±SD)	Liquefactive necrosis group (months) (median±SD)	P value
Overall survival	23.27±1.40	8.83±2.15	0.004
Progression-free survival	9.33±0.96	3.70±0.44	0.002
Intrahepatic in situ progression	12.23±1.74	5.53±1.29	0.008
New intrahepatic metastasis	14.33±1.32	7.20±0.66	0.009
Extrahepatic progression	15.27±3.24	6.67±1.29	0.011

SD – standard deviation. P<0.05 was considered a statistically significant difference.